Atlas Trials

Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension

Clinical trial NCT01963208 · COMPLETED

Trial details

NCT number
NCT01963208
Sponsor
Marinus Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Drug Resistant Partial Onset Seizure
Start date
2013-10-01
Primary completion
2016-05-01
Enrollment
405

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.